Alternatives to Nucleix

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

BioControl develops advanced diagnostic solutions for infectious diseases and cancer.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Develops a computational model of the human body for drug discovery and development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Infiniplex offers a comprehensive cancer screening platform utilizing advanced AI and multi-omic analysis.

Develops toilet-integrated diagnostic technology for early health condition detection.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

AI-powered early cancer detection using proprietary image and pattern recognition technology.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered blood test for early cancer detection and subtyping.